Global Healthcare Brands Eye India Opportunities - Chairman, Aaron Capital, Inc. USA

India Pharma Outlook Team | Monday, 04 March 2024

 Global Boutique, biomedical equipment, India Pharma Outlook

Photo:Representative Image

The current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues” - David Sanford Wolfe, Chairman, Aaron Capital, Inc USA.

Big global brands in the healthcare sector are keenly exploring opportunities in India, and one such brand is almost on the verge of signing an MoU in the country soon.

David Sanford Wolfe, Chairman of Aaron Capital, Inc. USA, said about five to six brands in the healthcare sector are expanding their base in India, and one of them is in the process of reaching an agreement with an Indian partner.

An announcement on this front is expected in the next few days, he said on the sidelines of Dr. D Y Patil's Lecture, organized by D Y Patil International University, Pune.

The healthcare sector is where India is not up to the mark, which creates a huge potential for investment by global investors. Hence, some of the big brands in the US healthcare sector are coming to India, he added while delivering his speech on ‘America is coming to India.’

He added that the current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues.

Aaron Capital Inc. is an agnostic Global Boutique Investment Banking Firm that operates in India through its affiliate, Aaron Financial Advisory India.

Prof Prabhat Ranjan, the University's Vice-Chancellor and former chief of Technology Information, Forecasting and Assessment Council, said.

He said that the country is a major importer of biomedical equipment and will be a game changer if the industry can develop the eco-system domestically.

According to Wolfe, the bilateral trade between India and the US has risen by 72 percent between 2017-18 and 2022-23. During 2022-23, the USA was the top destination of Indian exports to the world and the third source of India’s imports from the world. Further, he said India’s exports to the USA stood at $78.5 billion in 2022-23, and its imports from the USA were $50.2 billion.

© 2024 India Pharma Outlook. All Rights Reserved.